Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540 [aspirin/omeprazole], PA32540 and Celecoxib, and Aspirin With Celecoxib

Trial Profile

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540 [aspirin/omeprazole], PA32540 and Celecoxib, and Aspirin With Celecoxib

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jan 2010

At a glance

  • Drugs Aspirin; Aspirin/omeprazole; Celecoxib
  • Indications Arthritis; Cardiovascular disorders; Embolism and thrombosis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
  • Focus Pharmacodynamics
  • Acronyms PA32540-109
  • Most Recent Events

    • 09 Jan 2009 Acronym identified as PA32540-109 as reported by ClinicalTrials.gov.
    • 09 Jan 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 09 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top